Medical strategies of cardiovascular protection to reduce cancer therapy-related cardiovascular toxicity: where do we stand? [0.03%]
心血管保护医疗策略在减少癌症治疗相关的心血管毒性方面的作用？我们目前处于什么位置？
Daniel Lenihan,Joerg Herrmann
Daniel Lenihan
Cancer therapy has dramatically changed over the past many decades, not only in efficacy but also complexity, with targeted therapeutics that have novel mechanisms of action. As a direct result of these remarkable treatments that have exten...
Huimin Su,Julie De Backer,Jeroen Breckpot et al.
Huimin Su et al.
Congenital heart disease (CHD) is the most common congenital anomaly, with lifelong implications as survival into adulthood becomes the norm. Despite advances in prenatal detection, surgical care and long-term follow-up, the aetiology of CH...
When 'Intermediate' is not innocent: revisiting premature ventricular complex burden and left ventricular remodelling risk [0.03%]
当"中度"不再无辜：重新审视早搏负担和左心室重塑风险
Pouria Shoureshi,Jose F Huizar
Pouria Shoureshi
From natural to unnatural history of aortic valve stenosis: a tribute to Dr Braunwald's legacy [0.03%]
从主动脉瓣狭窄的自然史到非自然史：献给Braunwald博士的遗产
Pompilio Faggiano,Giacomo Gamberini,Catherine M Otto
Pompilio Faggiano
Preethi Saravanan,Sona Murugan,David Warriner
Preethi Saravanan
Refining evidence-based care for diverse bicuspid aortic valve phenotypes: addressing one piece of a larger puzzle [0.03%]
基于证据的二叶式主动脉瓣不同表型护理的完善：解决更大谜题的一部分问题
Ching-Hui Sia,William K F Kong
Ching-Hui Sia
No pain, no gain? The complexity of ST-elevation myocardial infarction without chest pain [0.03%]
有痛才有收获？STEMI无胸痛患者的诊疗难题
Stephane Manzo-Silberman
Stephane Manzo-Silberman
Is earlier better? Re-examining the timing of double sequential external defibrillation [0.03%]
早优于晚：二次序贯外同步电除颤时间窗的再探讨
Sheldon Cheskes
Sheldon Cheskes